Inventor · disambiguated record
Claire Langrish
Also filed as: LANGRISH CLAIRE · LANGRISH CLAIRE L · LANGRISH CLAIRE LOUISE
3 granted patents·12 pending applications·44 citations·filing 2004–2024
64Inventor score
Top patents by PatentIndex Score
15 records- 0193US8003099B2Antibodies against human IL17 and uses thereofROCHE PALO ALTO LLC·Filed 2009·Granted Aug 23, 2011·44 cites·17 claims
- 0272US2025221999A1Methods for Treating Immune Thrombocytopenia by Administering (R)-2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy- Phenyl) Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-EnenitrilePRINCIPIA BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0371US2025099470A1Topical Pharmaceutical Compositions Comprising 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4,4-Dimethylpent-2-EnenitrilePRINCIPIA BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0469US12178818B2Methods for treating immune thrombocytopenia by administering (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrilePRINCIPIA BIOPHARMA INC·Filed 2022·Granted Dec 31, 2024·0 cites·22 claims
- 0565US2023277542A1Topical Pharmaceutical Compositions Comprising 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4,4-Dimethylpent-2-EnenitrilePRINCIPIA BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0661US2009092604A1Method for the Treatment of Multiple Sclerosis by Inhibiting IL-17 ActivitySCHERING CORP·Filed 2008·Application pending·0 cites
- 0760US11583533B2Topical pharmaceutical compositions comprising 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrilePRINCIPIA BIOPHARMA INC·Filed 2021·Granted Feb 21, 2023·0 cites·32 claims
- 0855US2021106584A1Methods for treating immune thrombocytopenia by administering (r)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrilePRINCIPIA BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 0954US2006140950A1Uses of mammalian cytokine; related reagentsSCHERING CORP·Filed 2006·Application pending·0 cites
- 1054US2024207277A1Methods For Treating Drug and Vaccine Induced Immune Thrombocytopenia by Administering Specific CompoundsPRINCIPIA BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1150US2004219150A1Uses of mammalian cytokine; related reagentsFiled 2004·Application pending·0 cites
- 1247US2010143357A1Uses of Mammalian Cytokine; Related ReagentsSCHERING CORP·Filed 2010·Application pending·0 cites
- 1344US2023158031A1Treatment of Acute Respiratory Distress Syndrome and Other Disorders Involving Cytokine Storm Using BTK InhibitorsPRINCIPIA BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1440US2021205312A1TREATMENT OF MEMBRANOUS NEPHROPATHY, IGG4-RELATED DISEASE, AND ANTIPHOSPHOLIPID SYNDROME USING BTK INHIBITOR 2-[(3R)-3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-d]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILEPRINCIPIA BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1539US2013195844A1Antibodies against human il17 and uses thereofAUER JOHANNES·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Claire Langrish files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →